7.690USD-2.53%Mkt Cap: 396.78M $P/E: —1d ago
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationall…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap396.78M $
Enterprise Value821.08M $
Revenue (TTM)676.80M $
Gross Profit379.00M $
Net Income (TTM)52.60M $
Revenue/Share12.80 USD
Last Price7.690 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees900
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS29089Q1058
Valuation
P/E (Trailing)—
P/E (Forward)2.57
PEG0.38
EV/EBITDA4.92
EV/Revenue1.21
P/S0.59
P/B0.76
EPS (TTM)-0.19
EPS (Forward)2.99
52W Range
5.62025% of range14.06
52W High14.06 USD
52W Low5.620 USD
Profitability
Gross Margin53.74%
Oper. Margin6.79%
EBITDA Margin24.63%
Profit Margin7.46%
ROE10.07%
ROA3.99%
Growth
Revenue Growth-29.70%
Earnings Growth-93.80%
Cash Flow & Leverage
Operating CF170.60M $
CapEx (TTM)13.80M $
FCF Margin37.86%
FCF Yield64.57%
Net Debt424.30M $
Net Debt/EBITDA2.55
Balance Sheet
Debt/Equity1.09
Current Ratio4.29
Quick Ratio1.90
Book Value/Sh10.10 USD
Cash/Share3.107 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)12.00 USD
Upside (mean)+56.0%
Target Range12.00 USD – 12.00 USD
# Analysts2
Ownership
Shares Out.51.60M
Float49.38M
Insiders3.85%
Institutions87.07%
Short Interest
Short Ratio10.2d
Short % Float20.21%
Short % Out.19.90%
Shares Short10.27M
Short (prev mo.)9.76M
Technical
SMA 508.350 (-7.9%)
SMA 2009.719 (-20.9%)
Beta2.34
S&P 52W Chg20.25%
Avg Vol (30d)778.76K
Avg Vol (10d)785.73K
Technical Indicators
RSI (14)42.1
MACD-0.1319
MACD Signal-0.0805
MACD Hist.-0.0514
BB Upper8.635 USD
BB Middle8.114 USD
BB Lower7.592 USD
BB Width12.86%
ATR (14)0.3857 USD
Vol Ratio (20d)0.93x